Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has supplier | GlaxoSmithKline Inc. (supplier) | true | Inferred relationship | Some | ||
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Hepatitis B virus recombinant surface antigen | true | Inferred relationship | Some | 2 | |
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has product characteristic | enfance | false | Inferred relationship | Some | ||
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient characteristic (attribute) | faible dose | false | Inferred relationship | Some | 2 | |
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient characteristic (attribute) | faible dose | false | Inferred relationship | Some | 1 | |
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Pediatric vaccine product containing only Hepatitis A + hepatitis B antigens low strength (medicinal product) | true | Inferred relationship | Some | ||
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of inactivated whole Hepatitis A virus HM-175 strain (substance) | true | Inferred relationship | Some | 1 | |
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | faible dose | true | Inferred relationship | Some | 1 | |
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has target population | Pediatric population (qualifier value) | true | Inferred relationship | Some | ||
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | faible dose | true | Inferred relationship | Some | 2 | |
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Hepatitis A+B vaccine (product) | false | Inferred relationship | Some | ||
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Hepatitis A virus vaccine (substance) | false | Inferred relationship | Some | 2 | |
| Twinrix 360 ELISA units HAV and 10 micrograms HBV per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Hepatitis B virus vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR